Pathogenetic significance of oxidative stress in canine prostatic hyperplasia
Abstract
Canine prostatic hyperplasia is a common disease, mainly in older males, which is registered in animals regardless of breed, fatness and other factors. The pathogenesis of this disease in dogs is not well studied. One of its components – hormonal changes, has been studied in more depth, as a result of which it is known that the development of prostatic hyperplasia occurs due to impaired androgenesis, changes in the testosterone-estradiol ratio. On the contrary, data on the redox balance in prostate tissue during hyperplastic changes are scarce.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.